Works by Lokhande, Hrishikesh
Results: 16
Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjects.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.956907
- By:
- Publication type:
- Article
Accuracy of serum neurofilament light to identify contrast-enhancing lesions in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 11/12, p. 1418, doi. 10.1177/13524585231198751
- By:
- Publication type:
- Article
Early Predictors of Clinical and MRI Outcomes Using Least Absolute Shrinkage and Selection Operator (LASSO) in Multiple Sclerosis.
- Published in:
- Annals of Neurology, 2022, v. 92, n. 1, p. 87, doi. 10.1002/ana.26370
- By:
- Publication type:
- Article
A probiotic modulates the microbiome and immunity in multiple sclerosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort study.
- Published in:
- Journal of Neuroinflammation, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12974-023-02816-8
- By:
- Publication type:
- Article
miRNA 548a-3p as biomarker of NEDA-3 at 2 years in multiple sclerosis patients treated with fingolimod.
- Published in:
- Journal of Neuroinflammation, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12974-023-02811-z
- By:
- Publication type:
- Article
Author Correction: Ensemble learning predicts multiple sclerosis disease course in the SUMMIT study.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Author Correction: Ensemble learning predicts multiple sclerosis disease course in the SUMMIT study.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Ensemble learning predicts multiple sclerosis disease course in the SUMMIT study.
- Published in:
- NPJ Digital Medicine, 2020, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41746-020-00338-8
- By:
- Publication type:
- Article
Dissection of multiple sclerosis genetics identifies B and CD4+ T cells as driver cell subsets.
- Published in:
- Genome Biology, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13059-022-02694-y
- By:
- Publication type:
- Article
Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2022, p. 1, doi. 10.1177/20552173211069348
- By:
- Publication type:
- Article
Relapse recovery in multiple sclerosis: Effect of treatment and contribution to long-term disability.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, p. 1, doi. 10.1177/20552173211015503
- By:
- Publication type:
- Article
Relapse recovery in multiple sclerosis: Effect of treatment and contribution to long-term disability.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, v. 7, n. 2, p. 1, doi. 10.1177/20552173211015503
- By:
- Publication type:
- Article
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48602-9
- By:
- Publication type:
- Article
Key epigenetic and signaling factors in the formation and maintenance of the blood-brain barrier.
- Published in:
- eLife, 2024, p. 1, doi. 10.7554/eLife.86978
- By:
- Publication type:
- Article
Identification of TNFAIP3 as relapse biomarker and potential therapeutic target for MOG antibody associated diseases.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-69182-w
- By:
- Publication type:
- Article